TCL Archive CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments April 6, 1990
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.” September 30, 2005
